ask="4.05"
ask_size="300"
average_daily_volume="570575"
bid="3.50"
bid_size="900"
book_value="0.44"
change="+0.01"
change_from_200_day_moving_average="2.03"
change_from_50_day_moving_average="1.44"
change_from_52_week_high="-0.11"
change_From_52_week_low="3.11"
change_in_percent="+0.24%"
close="4.13"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.10"
ebitda="-24.72M"
eps_estimate_current_year="-1.13"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="-0.94"
ex_dividend_date="N/A"
float_shares="20320000"
high="4.20"
high_52_weeks="4.24"
last_trade_date="3/14/2017"
last_trade_price="4.13"
last_trade_size="681"
last_trade_time="4:00pm"
low="4.05"
low_52_weeks="1.02"
market_capitalization="96.84M"
moving_average_200_day="2.10"
moving_average_50_day="2.69"
name="CymaBay Therapeutics Inc."
notes="N/A"
one_year_target_price="5.67"
open="4.12"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+96.23%"
percent_change_from_50_day_moving_average="+53.42%"
percent_change_from_52_week_high="-2.59%"
percent_change_from_52_week_low="+304.90%"
previous_close="4.12"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="9.45"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="23447000"
short_ratio="0.89"
stock_exchange="NCM"
symbol="CBAY"
volume="183124"
weeks_range_52="1.02 - 4.24"
